Simulations Plus Sets Date for Second Quarter Earnings Release and Conference Call

* Reuters is not responsible for the content in this press release.

Thu Apr 10, 2008 9:15am EDT 

Conference Call to Be on Tuesday, April 15, at 4:15 PM EDT
LANCASTER, Calif.--(Business Wire)--
Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of
software for pharmaceutical discovery and development, today announced
that it will file its 10Q-SB quarterly report with the Securities and
Exchange Commission on Monday, April 14, and will hold an investor
conference call on Tuesday, April 15, at 1:15 PM PDT/ 4:15 PM EDT.

   Shareholders and interested parties may join the conference call
by dialing toll-free 877-604-9667, and referencing either 'Simulations
Plus Second Quarter Fiscal Year 2008 Results' or confirmation code
3480624. The conference call may also be accessed from outside the
United States by dialing 719-325-4851. Please dial-in five to ten
minutes prior to the scheduled start time. Playback should be
available on our web site within 72 hours.

   About Simulations Plus, Inc.

   Simulations Plus, Inc., is a premier developer of groundbreaking
drug discovery and development software, which is licensed to and used
in the conduct of drug research by pharmaceutical, biotechnology, and
drug delivery companies worldwide. The Company has two other
businesses, Words+, Inc. and FutureLab(TM), which are based on its
proprietary software technologies. Simulations Plus, Inc., is
headquartered in Southern California and trades on the NASDAQ under
the symbol "SLP." For more information, visit our Web site at
www.simulations-plus.com.

Simulations Plus, Inc.
Investor Relations:
Ms. Renee Bouche, 661-723-7723
info@simulations-plus.com
www.simulations-plus.com

Copyright Business Wire 2008
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.